Not a single study
Story checked
New data examine pediatric ADHD medication prior authorization policies in Medicaid managed care plans (opens in a new tab)
medicalxpress.com · 2026-09-11
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
New data examine pediatric ADHD medication prior authorization policies in Medicaid managed care plans
medicalxpress.com · 2026-09-11
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Source layer
The 3 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- Also referencedpresented as the new finding
Pediatric ADHD Medication Prior Authorization Policies in Medicaid Managed Care Plans
- Also referencedpresented as the new finding
Pediatric ADHD Medication Prior Authorization Policies in Medicaid Managed Care Plans
- Also referencedpresented as the new finding
Variation Across State Laws Could Facilitate Use of Telehealth for ADHD or Tourette Syndrome Diagnosis, Monitoring and Treatment
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedNew data published by the Center for Public Health Law Research at Temple University provide an in-depth look at prior authorization policies that apply to children younger than 18 in Medicaid managed care plans.View evidenceHide evidence
As statedin-depth look
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe data cover Medicaid managed care policies for the 50 U.S. states and the District of Columbia and describe policies governing access to ADHD medications as of Oct. 1, 2025, including prior authorization and age requirements and prerequisites for nonmedication alternatives.View evidenceHide evidence
As stated50 U.S. states and the District of Columbia
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedAs of Oct. 1, 2025, 158 Medicaid managed care plans across 31 states (including the District of Columbia) provide coverage for ADHD medications, and 129 plans impose prior authorization requirements or age restrictions for ADHD medications prescribed to children younger than 18.View evidenceHide evidence
As stated158 plans; 31 states; 129 plans
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedSeven managed care plans require concurrent behavioral therapy, a referral to behavioral therapy or proof of an impending appointment for behavioral therapy for medication to be covered, and 14 plans require a prior trial and/or concurrent failure of behavioral therapy for medication to be approved.View evidenceHide evidence
As stated7 plans; 14 plans
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedThe article frames these data as a first step toward understanding barriers to access children face and says state telehealth laws for ADHD or Tourette syndrome are part of a broader policy context affecting diagnosis, monitoring, and treatment.View evidenceHide evidence
As statedfirst step
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref, PubMed, Europe PMC · 39 candidate papers
The Role of International Law in Addressing Global Public Health Emergencies
European Journal of Integrative Medicinal and Allied Paramedical Spectrum Studies · 2026 · Crossref
Extraterritorial Application of the Obligation to Prevent Genocide
Center for Public Interest & Human Rights Law Chonnam National University · 2026 · Crossref
A Study of Court Rulings Invoking the Convention on the Rights of the Child
Center for Public Interest & Human Rights Law Chonnam National University · 2026 · Crossref
Mental Health and Individual Resilience in Contexts of Social Vulnerability: Evidence from Rural Texas
Community Mental Health Journal · 2026 · Crossref
Reducing private health expenditure in Greece: the case for regulated complementary health insurance
Frontiers in Public Health · 2026 · Crossref
And 34 more candidates considered.